Stocktoria
Autonomix Medical, Inc. AMIX
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2024-01-29
Autonomix Medical, Inc. financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| R&D expense | $7.1M | $4.7M | $2.2M | $745,000 |
| Operating income | -$17.0M | -$11.6M | -$12.0M | -$2.0M |
| Income tax | $0 | $0 | $0 | $0 |
| Net income | -$16.7M | -$11.4M | -$15.4M | -$2.0M |
| Operating cash flow | -$12.3M | -$8.3M | -$6.6M | -$1.9M |
| Free cash flow | -$12.3M | -$8.3M | -$6.6M | -$1.9M |
| Cash & equivalents | $7.0M | $9.1M | $8.6M | $865,000 |
| Total assets | $7.6M | $9.8M | $9.4M | $865,000 |
| Total liabilities | $1.7M | $1.7M | $1.8M | $221,000 |
| Shareholders' equity | $5.9M | $8.1M | $7.6M | $644,000 |
Source: SEC EDGAR filings · CIK 0001617867 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.